ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
GRI Bio Inc

GRI Bio Inc (GRI)

1.7226
0.0226
( 1.33% )
Updated: 11:10:12

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
1.7226
Bid
1.72
Ask
1.75
Volume
58,204
1.7226 Day's Range 1.87
0.205 52 Week Range 28.70
Previous Close
1.70
Open
1.73
Last Trade
3
@
1.7422
Last Trade Time
11:18:42
Average Volume (3m)
465,012
Financial Volume
$ 103,920
VWAP
1.7855

GRI Latest News

GRI Bio (NASDAQ: GRI) to Participate in the Virtual Investor Lunch Break Series

Live video webcast on Wednesday, July 17th at 12:00 PM ET LA JOLLA, CA, July 15, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio,” “we,” “our,” or the “Company”), a biotechnology...

GRI Bio (NASDAQ: GRI) Participates in Virtual Investor “What This Means” Segment

Marc Hertz, PhD, CEO of GRI Bio underscores importance of the interim data from their ongoing Phase 2a biomarker study for Idiopathic Pulmonary Fibrosis (IPF) LA JOLLA, CA, July 11, 2024 (GLOBE...

GRI Bio Regains Compliance with Nasdaq

LA JOLLA, CA, July 08, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (NKT) cell...

GRI Bio Announces Publication of Positive Preclinical Data from Lead Program GRI-0621 in the American Journal of Respiratory and Critical Care Medicine

Data demonstrates that NKT cells are activated in airways in IPF patients and inhibition of type 1 invariant NKT (iNKT) cell activity can ameliorate bleomycin-induced pulmonary fibrosis in mice...

GRI Bio to Present at the 8th Annual IPF Summit

LA JOLLA, CA, July 01, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”...

GRI Bio Announces Closing of $4.0 Million Public Offering

LA JOLLA, CA, June 28, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”...

GRI Bio Announces Korea Patent Granted for Proprietary Natural Killer T (NKT) Cell Modulators

Company is strategically building a global patent estate in key territories for a growing pipeline targeting potentially high-value indications in need of innovation LA JOLLA, CA, June 27, 2024...

GRI Bio Announces Pricing of $4 Million Public Offering

LA JOLLA, CA, June 27, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.08265.036585365851.641.93991.513878941.74597511CS
4-1.2974-42.96026490073.023.491.463705892.14284387CS
121.2715281.8665484370.45113.490.2054650120.79148616CS
26-0.4824-21.87755102042.20550.2056091511.27283273CS
52-25.9974-93.785714285727.7228.70.2054380222.81912259CS
156-90.6774-98.135714285792.493.310.2053644993.45081478CS
260-90.6774-98.135714285792.493.310.2053644993.45081478CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TKLFYoshitsu Company Ltd
$ 0.6287
(105.29%)
231.89M
SILOSilo Pharma Inc
$ 2.0999
(96.25%)
97.44M
NAASNaaS Technology Inc
$ 3.85
(37.50%)
9.07M
VRPXVirpax Pharmaceuticals Inc
$ 1.41
(31.78%)
9.77M
CDTConduit Pharmaceuticals Inc
$ 0.3133
(30.54%)
83.81M
AMIXAutonomix Medical Inc
$ 1.075
(-22.10%)
4.48M
CYNCYNGN Inc
$ 7.19
(-21.68%)
543.48k
ZEOZeo Energy Corporation
$ 3.26
(-17.47%)
32.15k
LGHLWLion Group Holding Ltd
$ 0.0073
(-17.05%)
45.45k
CMNDClearmind Medicine Inc
$ 1.845
(-16.89%)
1.75M
TKLFYoshitsu Company Ltd
$ 0.6287
(105.29%)
231.89M
SILOSilo Pharma Inc
$ 2.0999
(96.25%)
97.44M
NVDANVIDIA Corporation
$ 126.51
(-1.50%)
90.98M
CDTConduit Pharmaceuticals Inc
$ 0.3133
(30.54%)
83.81M
SQQQProShares UltraPro Short QQQ
$ 7.485
(0.34%)
56.8M

Your Recent History

Delayed Upgrade Clock